Magdalena Kuźma‐Kozakiewicz

SOD1 mutations associated with amyotrophic lateral sclerosis analysis of variant severity

Mariusz Berdyński, Przemysław Miszta, Krzysztof Safranow et al. · Scientific Reports · 2022 · 170 citations · Full text

Life Sciences, Genetics, Neurology +17

European Academy of Neurology (<scp>EAN)</scp> guideline on the management of amyotrophic lateral sclerosis in collaboration with European Reference Network for Neuromuscular Diseases (<scp>ERN</scp><scp>EURO‐NMD)</scp>

Philip Van Damme, Ammar Al‐Chalabi, Peter M. Andersen et al. · European Journal of Neurology · 2024 · 107 citations · Full text

Life Sciences, Neurology, Neuroscience +8

ROCK-ALS: Protocol for a Randomized, Placebo-Controlled, Double-Blind Phase IIa Trial of Safety, Tolerability and Efficacy of the Rho Kinase (ROCK) Inhibitor Fasudil in Amyotrophic Lateral Sclerosis

Paul Lingor, Markus Weber, William Camu et al. · Frontiers in Neurology · 2019 · 80 citations · Full text

Life Sciences, Neurology, Neuroscience +17

Multicentre quality control evaluation of different biomarker candidates for amyotrophic lateral sclerosis

Stefan Lehnert, Júlia Costa, Mamede de Carvalho et al. · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · 2014 · 68 citations

Life Sciences, Neurology, Neuroscience +17

An observational study on quality of life and preferences to sustain life in locked-in state

Magdalena Kuźma‐Kozakiewicz, Peter M. Andersen, Katarzyna Ciećwierska et al. · Neurology · 2019 · 67 citations · Full text

Medicine, Neurology, End-of-life Care +16